MedPath

Effects of exercise for chronic kidney patients during hemodialysis.

Not Applicable
Conditions
Renal Insufficiency, Chronic
Exercise
Renal Dialysis
Endurance Training
Resistance Training
C12.777.419.780.750
G11.427.410.698.277
E02.870.300
E02.760.169.063.500.387.250
E02.760.169.063.500.387.875
Registration Number
RBR-4xqpmm
Lead Sponsor
niversidade Federal do Triângulo Mineiro
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Inclusion: age over 18 years; due to the ease of travel and use of the consent form; being more than three months on hemodialysis, due to treatment adaptations; does not present any type of motor impairment that makes it impossible to evaluate and perform the exercise protocol, for patient and researcher safety. The conditions will be submitted to the medical staff of the renal replacement therapy unit; do not use medical contraindications for physical exercise; cognitive ability to understand the research process and sign the consent form; willingness to participate in the study.

Exclusion Criteria

Exclusion: Known unstable medical condition (angina, uncontrolled hypertension, congestive heart failure, arrhythmogenic heart disease); Neuromuscular disorders (myasthenia gravis, amyotrophic lateral sclerosis, congenital muscular dystrophies, cerebellar ataxias); Pacemaker carriers; Stop voluntarily participating in the study; Do not perform exercise sessions for two consecutive weeks; Discharge or abandon treatment; Not being collaborative in the proposed evaluations.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected Outcome 1: produce positive effects on anthropometry, body composition, body mass index (BMI), waist circumference (WC), systolic blood pressure (SBP) and diastolic blood pressure (DBP), through measurement before and after intervention and analysis statistics, (it is intended to obtain a statistically significant reduction in the parameters analyzed).;Expected outcome 2: produce positive effects on biochemical variables: lactate, triglycerides and HDL-c cholesterol, LDL-c, glycated hemoglobin (HBA1C), inflammatory markers (reduction of pro-inflammatory cytokines IL-1b, IL-6, IL-8 , TNF-a and increased anti-inflammatory cytokines IL-10), these parameters will be analyzed from laboratory tests and compared statistically.<br>
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are not expected.
© Copyright 2025. All Rights Reserved by MedPath